JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Čes-slov Pediat 2024, 79(6):341-348 | DOI: 10.55095/CSPediatrie2024/041

Causes of hyperCKemia in children

Patrícia Balážová1, Karin Viestová1, Ivan Martinka2, Miriam Kolníková1
1 Klinika detskej neurológie, Lekárska fakulta, Univerzita Komenského a Národný ústav detských chorôb, Bratislava
2 Neurologická klinika, Univerzitná nemocnica Bratislava a Slovenská zdravotnícka univerzita, Bratislava

Creatine kinase (CK) is an enzyme located in tissues with high energy demands, such as skeletal muscles or myocardium. It plays an essential role in cells' energy metabolism. The level of CK in the blood reflects the muscle membrane'

s integrity, and elevated CK levels can indicate muscle damage. However, diagnosing the cause of elevated CK levels in children requires the expertise of an experience

d pediatrician. This may be due to not only neuromuscular diseases but also a range of other diseases.

Keywords: creatine kinase, hyperCKemia, neuromuscular disorders

Received: May 12, 2024; Revised: June 21, 2024; Accepted: June 24, 2024; Published: December 1, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Balážová P, Viestová K, Martinka I, Kolníková M. Causes of hyperCKemia in children. Ces-slov Pediat. 2024;79(6):341-348. doi: 10.55095/CSPediatrie2024/041.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Voháňka S. Zvýšená hladina kreatinkinázy. Interní Med 2012; 14: 322-6.
    2. Aujla RS, Patel R. Creatine phosphokinase. StatPearls. Treasure Island (FL): StatPearls Publishing 2023.
    3. Brancaccio P, Maffulli N, Limongelli FM. Creatine kinase monitoring in sport medicine. British Medical Bulletin 2007; 81-82: 209-30. Go to original source... Go to PubMed...
    4. Al-twaijri WA, Al-saif SA, Al-fehaid GI, et al. Elevated level of creatine phosphokinase in newborn: Clinical significance and association with congenital muscle diseases. Neurosciences (Riyadh) 2022; 27: 263-9. Go to original source... Go to PubMed...
    5. Maloney B, Park S, Sowizral M, et al. Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy. Clin Biochemistry 2023; 118: 110614. Go to original source... Go to PubMed...
    6. Kyriakides T, Angelini C, Schaefer J, et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol 2010; 17: 767-73. Go to original source... Go to PubMed...
    7. Brewster LM, Mairuhu G, Sturk A, et al. Distribution of creatine kinase in the general population: implications for statin therapy. Am Heart J 2007; 154: 655-61. Go to original source... Go to PubMed...
    8. High intensity resistance training causes muscle damage and increases biomarkers of acute kidney injury in healthy individuals. PLOS ONE. Dostupné na: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0205791
    9. Narayanappa G, Nandeesh BN. Infective myositis. Brain Pathol 2021; 31: e12950. Go to original source... Go to PubMed...
    10. Terlizzi V, Improta F, Raia V. Simple diagnosis of benign acute childhood myositis: Lessons from a case report. J Pediatr Neurosci 2014; 9: 280-2. Go to original source... Go to PubMed...
    11. Costa Azevedo A, Costa e Silva A, Juliana Silva C, et al. Benign acute childhood myositis: A 5-year retrospective study. Archives de Pédiatrie 2022; 29: 490-3. Go to original source... Go to PubMed...
    12. Brisca G, Mariani M, Pirlo D, et al. Management and outcome of benign acute childhood myositis in pediatric emergency department. Italian J Pediatrics 2021; 47: 57. Go to original source... Go to PubMed...
    13. Cui H, Zhang X. Thyrotoxic myopathy: research status, diagnosis, and treatment. Endokrynologia Polska 2022; 73: 157-62. Go to original source... Go to PubMed...
    14. Mazanec R. Neuromuskulární poruchy u tyreopatie. Neurologie pro praxi. 2012; 13: 22-5.
    15. Fariduddin MM, Bansal N. Hypothyroid Myopathy. StatPearls. Treasure Island (FL): StatPearls Publishing 2023.
    16. Sindoni A, Rodolico C, Pappalardo MA, et al. Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. Rev Endocr Metab Disord 2016; 17: 499-519. Go to original source... Go to PubMed...
    17. Liu C-Y, Lai Y-C, Wu Y-C, et al. Macroenzyme creatine kinase in the era of modern laboratory medicine. J Chinese Med Association 2010; 73: 35-9. Go to original source... Go to PubMed...
    18. Hsiao J, Ning H, Gu P, et al. Clinical role of recurrently elevated macro creatine kinase type 1. J Clin Lab Anal 2008; 22: 186-91. Go to original source... Go to PubMed...
    19. Komrsková J, Franeková J, Jabor A. Makro-komplexy a možnosti jejich detekce. Klinická biochemie a metabolismus 2019; 24: 172. Go to original source...
    20. Venance SL. Approach to the patient with hyperCKemia. Continuum (Minneap Minn) 2016; 22: 1803-14. Go to original source... Go to PubMed...
    21. Venugopal V, Pavlakis S. Duchenne muscular dystrophy. StatPearls. Treasure Island (FL): StatPearls Publishing 2023.
    22. Darras BT, Urion DK, Ghosh PS. Dystrophinopathies. In: Adam MP, Feldman J, Mirzaa GM, et al. (eds.). GeneReviews®. Seattle (WA): University of Washington, Seattle 1993.
    23. Papadopoulou C, Chew C, Wilkinson MGLl, et al. Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care. Nat Rev Rheumatol 2023; 19: 343-62. Go to original source... Go to PubMed...
    24. Rider LG, Nistala K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. J Intern Med 2016; 280: 24-38. Go to original source... Go to PubMed...
    25. Tansley SL, McHugh NJ, Wedderburn LR. Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms? Arthritis Res Ther 2013; 15: 211. Go to original source... Go to PubMed...
    26. Wang C-H, Liang W-C. Pediatric immune-mediated necrotizing myopathy. Front Neurol 2023; 14. Go to original source... Go to PubMed...
    27. Marques JS. The clinical management of Pompe disease: a pediatric perspective. Children (Basel) 2022; 9: 1404. Go to original source... Go to PubMed...
    28. Merritt JL, Norris M, Kanungo S. Fatty acid oxidation disorders. Ann Transl Med 2018; 6: 473. Go to original source... Go to PubMed...
    29. Nishio H, Niba ETE, Saito T, et al. Spinal muscular atrophy: the past, present, and future of diagnosis and treatment. Int J Mol Sci 2023; 24: 11939. Go to original source... Go to PubMed...
    30. Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 2018; 28: 103-15. Go to original source... Go to PubMed...
    31. Jordan A, Nagaraj A, Hoyle JC, et al. Elevated creatinine kinase in peripheral neuropathy is associated with muscle cramping. Front Neurol 2021; 12: 613599. Go to original source... Go to PubMed...
    32. Hopkins PM, Girard T, Dalay S, et al. Malignant hyperthermia 2020. Anaesthesia 2021; 76: 655-64. Go to original source... Go to PubMed...
    33. Kurapati R, Soos MP. CPK-MB. StatPearls. Treasure Island (FL): StatPearls Publishing 2024.
    34. Zafar Gondal A, Foris LA, Zubair M, et al. Serum myoglobin. StatPearls. Treasure Island (FL): StatPearls Publishing 2024.
    35. Sethuraman C. Muscle biopsies in children - a broad overview and recent updates: where does the future lie? Diagnostic Histopathol 2023; 29: 511-20. Go to original source...
    36. Wong W-K, Bryen SJ, Bournazos A, et al. A genetic basis is identified in 74% cases of paediatric hyperCKaemia without weakness presenting to a tertiary paediatric neuromuscular centre. Neuromuscul Disord 2022; 32: 707-17. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content